Intracellular cAMP levels are also raised in exendin-4-treated post-transient middle cerebral artery occlusion as a result of increased GLP1R expression (Teramoto et al., 2011; Kim et al., 2017). The gene discussed is GLP1R; the disease is cerebritis.